Third Annual UMass Department of Neurology Clinical & Research Updates Agenda
Friday, November 12, 2021, 12:30 p.m. to 5:25 p.m. |
|
12:30 | Click Here to join the Zoom |
12:40 | Carolina Ionete MD, PhD, Professor of Neurology - Program Co-Director Opening Remarks |
12:45 | KEYNOTE: Robert H. Brown, Jr., MD DPhil, Vice-Chair for Research and Professor of Neurology Recent Advances in Hereditary and Sensory Autonomic Neuropathy HSAN1: From Rare toward Common Phenotypes |
1:15 | Janice Dominov, PhD Assistant Professor of Neurology Dysferlinopathy Pathogenesis and Development of New Therapeutic Strategies |
1:35 | Lawrence Hayward MD, PhD, Professor of Neurology Update on Facioscapulohumeral Muscular Dystrophy (FSHD): Cellular Models and New Approaches to Therapy |
1:55 | Break |
2:05 | Charles Emerson, Jr. PhD Professor of Neurology Patient iPSCs for development of gene editing therapeutics for human muscular dystrophies |
2:25 | Daryl Bosco PhD, Professor of Neurology - Program Co-Director Elucidating mechanisms underlying neurodegeneration with iPSC-derived cells |
2:45 | Break |
2:55 | Brian Silver MD, FRCPC, FAHA, FAAN, FANA, Chair and Professor of Neurology- Program Co-Director Tenecteplase vs Alteplase for Acute Ischemic Stroke |
3:15 | Majaz Moonis MD, Professor of Neurology Advances in Stroke Prevention |
3:35 | Ajit S. Puri MD, Professor of Radiology, Neurosurgery and Neurology Stroke Thrombectomy-trials, current evidence and future implications |
3:45 | Break |
3:55 | Felicia Chu MD, Assistant Professor of Neurology Seizure Detection Devices |
4:15 | Kyle Rossi, MD, Assistant Professor of Neurology Electroencephalography in 2021: An update on modalities and utility of EEG |
4:45 | Neville Jadeja MD, Assistant Professor of Neurology New Antiepileptic Drugs |
5:05 | Adjourn for the day |
Saturday, November 13, 2021, 8:30 a.m. to 1:55 p.m. |
|
8:30 | Click Here to join the Zoom |
8:40 | Brian Silver MD, FRCPC, FAHA, FAAN, FANA, Chair and Professor of Neurology - Program Co-Director Opening Remarks |
8:50 | Andrew Galica, MD, Neurorehabilitation Fellow Neurorehabilitation and neurorecovery: current concepts and updates |
9:10 | Nils Henninger, M.D., Ph.D., Dr. Med., FANA, FWSO, Professor of Neurology Modeling TBI in the mouse to elucidate mechanistic links between brain injury, axonal degeneration, and aberrant tau accumulation after closed head injury |
9:30 | Susanne Muehlschlegel, MD, MPH, FNCS, FCCM, FAAN, Professor of Neurology Neuroprognostication in severe acute brain injury |
9:50 | Break |
10:00 | Elaine Teng-Ting Lim, PhD, Assistant Professor of Molecular, Cell and Cancer Biology Fine-mapping neurodevelopment timepoints of a complex locus |
10:20 | Yingleong (Rigel) Chan, PhD, Assistant Professor of Neurology Multiplex population in-vitro modeling of complex diseases |
10:40 | Delia Bakeman, MD, Assistant Professor of Neurology The Future of Alzheimer's |
11:00 | Break |
11:10 | Anindita Deb MD, Assistant Professor of Neurology Updates in medical management of Movement disorders |
11:30 | Wissam Deeb MD, Associate Professor, Department of Neurology Neurostimulation for Movement disorders: A New Era in DBS Therapy |
11:50 | Ari Wilkenfeld MD PhD, Assistant Professor of Neurology Treating Parkinson’s disease in a pandemic |
12:10 | Idanis Berrios, MD, Assistant Professor of Neurology Update on new DMT's use in Multiple Sclerosis |
12:30 | Christopher Hemond, MD, Assistant Professor of Neurology Updates on the identification and treatment of smoldering neuroinflammation in MS |
12:50 | Carolina Ionete MD, PhD, Professor of Neurology - Program Co-Director New biomarkers and The Use of Innovative Target Therapies in Sjogren’s Syndrome |
1:10 | Adjourn for the Program |
Organizing Committee |
Presentations Videos:
Accreditation Statement:
The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement:
The University of Massachusetts Medical School designates this internet live course for a maximum of 9 AMA PRA Category 1 Credit(s) ™.
Physicians should claim only credit commensurate with the extent of their participation in the activity.
Nursing: This offering meets the requirements for a maximum of 10.8 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.
Other Health Professionals: Will receive a certificate which states the activity was designated for 9 AMA PRA Category 1 credits™